YDES
YD Bio Ltd
NASDAQ: YDES · HEALTHCARE · BIOTECHNOLOGY
$5.11
-1.53% today
Updated 2026-04-30
Market cap
$385.05M
P/E ratio
—
P/S ratio
754.46x
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$5 – $25
Volume
0.0M
YD Bio Ltd (YDES) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Operating cash flow | $-253625.00 | $-688415.00 | $-3.02M | $-55657.00 | $-1.84M |
| Capital expenditures | $5.00 | $5.00 | $0.00 | $290.00 | $2.91M |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — |
| Free cash flow | $-253630.00 | $-688420.00 | $-3.02M | $-55947.00 | $-4.75M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |